<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 10.5: Thyroid Health in Men: Testosterone and Libido</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE/TEAL theme for Thyroid */
        .module-header {
            background: linear-gradient(135deg, #0f766e 0%, #14b8a6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #0f766e;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #0f766e;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #0f766e;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        @media (max-width: 600px) {
            .toc-list {
                grid-template-columns: 1fr;
            }
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0fdfa;
            border: 2px solid #14b8a6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #0f766e;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #0f766e;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #14b8a6;
        }

        .term-item .term {
            font-weight: 700;
            color: #0f766e;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #0f766e;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Welcome/Intro Box */
        .welcome-box {
            background: linear-gradient(135deg, #f0fdfa 0%, #f0fdf4 100%);
            padding: 30px 35px;
            border-radius: 14px;
            margin-bottom: 40px;
            border: 1px solid #ccfbf1;
        }

        .welcome-box h3 {
            margin: 0 0 15px 0;
            font-size: 20px;
            color: #0f766e;
            font-weight: 600;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #0f766e 0%, #14b8a6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #14b8a6, #0f766e);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #0f766e 0%, #14b8a6 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Tables */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        .data-table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            background: white;
        }

        .data-table th {
            background: #f1f5f9;
            padding: 15px;
            text-align: left;
            border-bottom: 2px solid #e2e8f0;
            color: #0f766e;
        }

        .data-table td {
            padding: 15px;
            border-bottom: 1px solid #f1f5f9;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
            position: relative;
        }

        .reveal-btn {
            background: #0f766e;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            font-family: inherit;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #0f766e;
            margin: 14px 0 0 0;
            padding: 14px;
            background: #f0fdfa;
            border-radius: 8px;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f8fafc;
            padding: 25px;
            border-radius: 12px;
            border: 1px solid #e2e8f0;
            margin-top: 40px;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #ffffff;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            margin-bottom: 15px;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 10: Thyroid Health Across the Lifespan</p>
            <h1 class="lesson-title">Lesson 10.5: Thyroid Health in Men: Testosterone and Libido</h1>
            <div class="lesson-meta">
                <span class="meta-item">32 min read</span>
                <span class="meta-item">Lesson 5 of 6</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Invisible Epidemic</a></li>
                <li><a href="#section2"><span class="section-num">2</span>The HPT-HPG Axis Cross-Talk</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Thyroid, SHBG, and Free Testosterone</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Sexual Dysfunction Mechanisms</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Thyroid vs. Hypogonadism</a></li>
                <li><a href="#section6"><span class="section-num">6</span>THRIVE Strategies for Men</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze the physiological mechanisms by which thyroid hormones regulate Leydig cell function and steroidogenesis.</li>
                <li>Explain the inverse relationship between thyroid status and Sex Hormone Binding Globulin (SHBG) in men.</li>
                <li>Differentiate between symptoms of primary hypogonadism and thyroid-induced low testosterone.</li>
                <li>Apply the THRIVE methodology to assess male-specific biomarkers beyond the standard TSH screening.</li>
                <li>Identify the prevalence of sexual dysfunction in male thyroid patients and evidence-based recovery timelines.</li>
            </ul>
        </div>

        <div class="welcome-box">
            <h3>The Forgotten Demographic</h3>
            <p>While thyroid disease is statistically 5 to 8 times more common in women, this disparity often leads to significant diagnostic delays in men. In male patients, thyroid dysfunction frequently masquerades as "age-related" low testosterone or simple burnout. As a practitioner, understanding the male endocrine landscape is critical; thyroid hormones are not just metabolic regulatorsâ€”they are essential co-factors for the production and utilization of androgens.</p>
        </div>

        <h2 id="section1">The Invisible Epidemic: Male Thyroid Dysfunction</h2>
        <p>In clinical practice, men often present with thyroid issues much later in the disease progression than women. Because the "standard" male profile for fatigue is often attributed to low testosterone (Hypogonadism), the thyroid is frequently overlooked. However, a 2021 meta-analysis published in the <i>Journal of Clinical Endocrinology</i> found that approximately <span class="highlight">6.3% of men presenting specifically for erectile dysfunction</span> had undiagnosed thyroid disorders.</p>

        <p>Furthermore, the autoimmune component (Hashimotoâ€™s) is often more aggressive in men when it does occur, yet men are less likely to be screened for TPO antibodies. This delay in diagnosis can lead to secondary complications, including cardiovascular strain and profound psychological distress related to sexual performance and "brain fog."</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">80%</div>
                    <div class="stat-label">Hyperthyroid men with ED</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">52%</div>
                    <div class="stat-label">Hypothyroid men with ED</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">10x</div>
                    <div class="stat-label">Higher risk of Low T</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">4.5m</div>
                    <div class="stat-label">Undiagnosed US Men</div>
                </div>
            </div>
        </div>

        <h2 id="section2">The HPT-HPG Axis Cross-Talk</h2>
        <p>The <span class="highlight">Hypothalamic-Pituitary-Thyroid (HPT) axis</span> and the <span class="highlight">Hypothalamic-Pituitary-Gonadal (HPG) axis</span> are not isolated systems; they are deeply integrated. Thyroid hormones (specifically T3) have specific receptors on the Leydig cells within the testes. These cells are responsible for producing testosterone in response to Luteinizing Hormone (LH).</p>

        <p>When T3 levels are insufficient (Hypothyroidism), the Leydig cells become less responsive to LH signals. This results in a "bottleneck" where the brain may be signaling for more testosterone, but the "machinery" in the testes lacks the metabolic "spark" to produce it. Conversely, excess thyroid hormone (Hyperthyroidism) can lead to a premature "burnout" of these cells and an overproduction of estrogen through increased aromatase activity.</p>

        <h2 id="section3">Thyroid, SHBG, and Free Testosterone</h2>
        <p>One of the most critical concepts in male thyroid health is the role of <span class="highlight">Sex Hormone Binding Globulin (SHBG)</span>. SHBG is a protein produced by the liver that "carries" testosterone through the blood. Only "Free Testosterone" (that which is not bound to SHBG or albumin) is biologically active and able to enter cells.</p>

        <div class="principle-card">
            <div class="principle-title">The SHBG Seesaw</div>
            <p class="principle-text">Thyroid hormone directly stimulates the production of SHBG in the liver. This creates two distinct clinical scenarios:</p>
            <ul>
                <li><strong>Hypothyroidism:</strong> Low thyroid hormones lead to <span class="highlight">Low SHBG</span>. While this might seem like it would increase "free" testosterone, it actually accelerates the clearance of testosterone from the body, leading to low total levels and disrupted androgen signaling.</li>
                <li><strong>Hyperthyroidism:</strong> High thyroid hormones lead to <span class="highlight">High SHBG</span>. This "soaks up" the available testosterone, leaving the man with very low <i>Free Testosterone</i>, despite having a normal or even high <i>Total Testosterone</i> reading.</li>
            </ul>
        </div>

        <h2 id="section4">Sexual Dysfunction Mechanisms</h2>
        <p>Sexual health in men is a complex interplay of vascular, neurological, and hormonal factors. Thyroid hormones influence all three. Hypothyroidism is strongly associated with <span class="highlight">Delayed Ejaculation</span> and reduced libido, while Hyperthyroidism is more frequently linked to <span class="highlight">Premature Ejaculation</span> and erectile instability.</p>

        <p>A landmark study by Carani et al. (2005) demonstrated that treating the underlying thyroid condition aloneâ€”without testosterone replacement therapyâ€”resolved sexual dysfunction in over 70% of participants within 6 to 12 months of achieving euthyroid (normal) status. This highlights the importance of the <b>"H" (Hormonal Synergy)</b> in the THRIVE Method.</p>

        <h2 id="section5">Thyroid vs. Hypogonadism: Symptom Comparison</h2>
        <p>Because the symptoms overlap so significantly, practitioners must look for subtle clues to distinguish between a primary testosterone issue and a thyroid-driven hormonal shift.</p>

        <div class="data-table-container">
            <table class="data-table">
                <thead>
                    <tr>
                        <th>Symptom</th>
                        <th>Primary Hypothyroidism</th>
                        <th>Primary Hypogonadism (Low T)</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Fatigue</strong></td>
                        <td>Constant, worse in morning, "heavy" limbs</td>
                        <td>Mid-afternoon crash, lack of "drive"</td>
                    </tr>
                    <tr>
                        <td><strong>Body Composition</strong></td>
                        <td>Generalized weight gain, myxedema (puffiness)</td>
                        <td>Increased abdominal fat, loss of muscle mass</td>
                    </tr>
                    <tr>
                        <td><strong>Mental Health</strong></td>
                        <td>Brain fog, forgetfulness, depression</td>
                        <td>Irritability, low motivation, "grumpy old man"</td>
                    </tr>
                    <tr>
                        <td><strong>Temperature</strong></td>
                        <td>Cold intolerance, low basal body temp</td>
                        <td>Normal or occasional night sweats</td>
                    </tr>
                    <tr>
                        <td><strong>Hair</strong></td>
                        <td>Loss of outer 1/3 of eyebrow, brittle hair</td>
                        <td>Loss of body/facial hair (rare in mild cases)</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The "Low T" Trap</p>
                    <p style="color: rgba(255,255,255,0.8); margin:0; font-size:13px;">Applying the THRIVE Methodology</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">M</div>
                    <div class="patient-info">
                        <h4>Mark, 44 years old</h4>
                        <p>Presenting with low libido, erectile dysfunction, and 15lb weight gain.</p>
                    </div>
                </div>
                <p><strong>Initial Assessment:</strong> Mark had been prescribed Testosterone Cypionate (TRT) by a local clinic after a Total Testosterone reading of 280 ng/dL. After 3 months on TRT, his testosterone was 750 ng/dL, but his symptoms (libido and fatigue) had not improved.</p>
                <p><strong>THRIVE Intervention:</strong>
                    <ul>
                        <li><strong>Targeted Biomarker Assessment (T):</strong> Full panel revealed TSH 5.2, Free T3 2.4 (Low), and positive TPO Antibodies (145).</li>
                        <li><strong>Hormonal Synergy (H):</strong> Identified that Mark's "Low T" was secondary to thyroid-driven low SHBG and impaired Leydig cell function.</li>
                        <li><strong>Vital Micronutrient Optimization (V):</strong> Added Selenium (200mcg) and Zinc (30mg) to support T4-T3 conversion and androgen synthesis.</li>
                    </tr>
                </p>
                <p><strong>Outcome:</strong> After 4 months of thyroid support and dietary changes to reduce inflammation (I), Mark's Free T3 rose to 3.2. His libido returned, and he was able to successfully taper off TRT while maintaining a natural Total Testosterone of 510 ng/dL.</p>
            </div>
        </div>

        <h2 id="section6">THRIVE Strategies for Male Thyroid Recovery</h2>
        <p>When working with male clients, the focus must shift toward protecting the androgenic pathways while restoring thyroid function. The THRIVE Method provides a specific framework for this:</p>

        <div class="principle-card">
            <div class="principle-title">T: Targeted Biomarker Assessment</div>
            <p class="principle-text">Never accept a TSH-only screening. For men, you must also see:</p>
            <ul>
                <li><strong>Free T3:</strong> The "fuel" for the Leydig cells.</li>
                <li><strong>SHBG:</strong> To determine the accuracy of testosterone readings.</li>
                <li><strong>Total and Free Testosterone:</strong> To assess the HPG axis health.</li>
                <li><strong>Estradiol (E2):</strong> To ensure thyroid-driven aromatase isn't converting too much T to Estrogen.</li>
            </ul>
        </div>

        <div class="principle-card">
            <div class="principle-title">V: Vital Micronutrient Optimization</div>
            <p class="principle-text">Men have unique micronutrient requirements for dual-axis support. <b>Zinc</b> is a dual-action nutrient, required for the TSH receptor and for the conversion of androstenedione to testosterone. <b>Selenium</b> protects the thyroid from oxidative stress while also supporting sperm motility and quality.</p>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of male thyroid physiology.</p>

            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">How does hyperthyroidism typically affect Sex Hormone Binding Globulin (SHBG) and Free Testosterone levels?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text">Hyperthyroidism increases SHBG production in the liver. High SHBG binds more testosterone, which often results in low levels of biologically active "Free Testosterone," even if Total Testosterone appears normal or high.</p>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">According to the HPT-HPG axis cross-talk, where does T3 exert its primary influence on testosterone production?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text">T3 has specific receptors on the Leydig cells within the testes, where it stimulates steroidogenesis (the production of testosterone) and increases the responsiveness of these cells to Luteinizing Hormone (LH).</p>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>Thyroid dysfunction is a significant, often undiagnosed cause of male sexual dysfunction and low libido.</li>
                <li>Thyroid hormones directly regulate the production of SHBG, which dictates how much testosterone is actually available to the tissues.</li>
                <li>Hypothyroidism is frequently associated with delayed ejaculation, while hyperthyroidism is linked to premature ejaculation.</li>
                <li>Treating the thyroid can often resolve "Low T" symptoms without the need for lifelong Testosterone Replacement Therapy (TRT).</li>
                <li>Comprehensive testing (the "T" in THRIVE) is mandatory to differentiate between primary hypogonadism and thyroid-induced hormonal shifts.</li>
            </ul>
        </div>

        <div class="references-box">
            <p style="font-weight: 600; color: #333; margin-bottom: 15px;">References & Further Reading</p>
            <p>1. Carani et al. (2005). "Multicenter Study on the Prevalence of Sexual Symptoms in Male Hypo- and Hyperthyroid Patients." <i>The Journal of Clinical Endocrinology & Metabolism.</i></p>
            <p>2. Gabrielson et al. (2021). "The Impact of Thyroid Dysfunction on Male Reproductive Health and Sexual Function." <i>Journal of Sexual Medicine.</i></p>
            <p>3. Krassas et al. (2010). "Thyroid Function and Human Reproductive Health." <i>Endocrine Reviews.</i></p>
            <p>4. Meikle, A. W. (2004). "The Interrelationships Between Thyroid Function and Endocrine Systems of the Testes." <i>Thyroid Journal.</i></p>
            <p>5. La Vignera et al. (2012). "Hyperthyroidism and Erectile Dysfunction: A Systematic Review." <i>Andrologia.</i></p>
            <p>6. Moncada et al. (2018). "Prevalence of Thyroid Dysfunction in Men with Erectile Dysfunction." <i>International Journal of Impotence Research.</i></p>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Certified Thyroid Health Coach</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All rights reserved. Professional Certification Program.</p>
        </footer>
    </div>
</body>

</html>